These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

76 related articles for article (PubMed ID: 486417)

  • 1. Quantitative assessment of the noncovalent inhibition of sickle hemoglobin gelation by phenyl derivatives and other known agents.
    Behe MJ; Englander WS
    Biochemistry; 1979 Sep; 18(19):4196-201. PubMed ID: 486417
    [TBL] [Abstract][Full Text] [Related]  

  • 2. The effect of phenylalanine derivatives on the solubility of deoxyhemoglobin S. A model class of gelation inhibitors.
    Noguchi CT; Ackerman S; DiMaio J; Schiller PW; Schechter AN
    Mol Pharmacol; 1983 Jan; 23(1):100-3. PubMed ID: 6865893
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Noncovalent inhibitors of sickle hemoglobin gelation: effects of tetrasubstituted ammonium salts.
    Mazhani L; Kim BC; Poillon WN
    Hemoglobin; 1984; 8(2):129-36. PubMed ID: 6469693
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Inhibition of sickle hemoglobin gelation by amino acids and related compounds.
    Noguchi CT; Schechter AN
    Biochemistry; 1978 Dec; 17(25):5455-9. PubMed ID: 728408
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Noncovalent inhibitors of sickle hemoglobin gelation: effects of aryl-substituted alanines.
    Poillon WN
    Biochemistry; 1982 Mar; 21(6):1400-6. PubMed ID: 7074094
    [No Abstract]   [Full Text] [Related]  

  • 6. Chemical modifications that inhibit gelation of sickle hemoglobin.
    Benesch R; Benesch RE; Yung S
    Proc Natl Acad Sci U S A; 1974 Apr; 71(4):1504-5. PubMed ID: 4524653
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Peptide inhibitors of sickle hemoglobin aggregation: effect of hydrophobicity.
    Gorecki M; Votano JR; Rich A
    Biochemistry; 1980 Apr; 19(8):1564-8. PubMed ID: 7378365
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Quantitative structure-activity relationship of phenoxy and benzyloxy acid derivatives as antisickling agents.
    Mahran MA
    Boll Chim Farm; 2000; 139(2):73-80. PubMed ID: 10920532
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Antigelling and antisickling bisphenyl oligopeptides and peptide analogues have similar structural features.
    Burley SK; Wang AH; Votano JR; Rich A
    Biochemistry; 1987 Aug; 26(16):5091-9. PubMed ID: 3663644
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Noncovalent inhibitors of sickle hemoglobin gelation: effects of aliphatic alcohols, amides, and ureas.
    Poillon WN
    Biochemistry; 1980 Jul; 19(14):3194-9. PubMed ID: 7407040
    [No Abstract]   [Full Text] [Related]  

  • 11. Sickle hemoglobin gelation. Reaction order and critical nucleus size.
    Behe MJ; Englander SW
    Biophys J; 1978 Jul; 23(1):129-45. PubMed ID: 667302
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Quantitative structure-activity relationships of cysteine hydrolases. Ficin hydrolysis of X-phenyl-N-methanesulfonyl glycinates.
    Carotti A; Raguseo C; Hansch C
    Chem Biol Interact; 1985 Jan; 52(3):279-88. PubMed ID: 2982507
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Potential use of biaromatic L-phenylalanyl derivatives as therapeutic agents in the treatment of sickle cell disease.
    Votano JR; Altman J; Wilchek M; Gorecki M; Rich A
    Proc Natl Acad Sci U S A; 1984 May; 81(10):3190-4. PubMed ID: 6587344
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Quantitative structure-activity relationships of inhibitors of immune complex-induced inflammation: 1-phenyl-3-aminopyrazoline derivatives.
    Kim KH; Martin YC; Norris B; Young PR; Carter GW; Haviv F; Walters RL
    J Pharm Sci; 1990 Jul; 79(7):609-13. PubMed ID: 2144591
    [TBL] [Abstract][Full Text] [Related]  

  • 15. QSAR and molecular shape analysis of aryl-substituted alanine analogs as antigelling agents.
    Yuan CJ; Hopfinger AJ; Johnson ME
    J Theor Biol; 1989 Nov; 141(1):41-52. PubMed ID: 2634159
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Novel aldose reductase inhibitors derived from 6-[[(diphenylmethylene)amino]oxy]hexanoic acid.
    Rakowitz D; Piccolruaz G; Pirker C; Matuszczak B
    Arch Pharm (Weinheim); 2007 Apr; 340(4):202-8. PubMed ID: 17351966
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Edge-to-face CH/pi interaction between ligand Phe-phenyl and receptor aromatic group in the thrombin receptor activation.
    Matsushima A; Fujita T; Nose T; Shimohigashi Y
    J Biochem; 2000 Aug; 128(2):225-32. PubMed ID: 10920258
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Effect of other hemoglobins on gelation of sickle cell hemoglobin.
    Sunshine HR
    Tex Rep Biol Med; 1980-1981; 40():233-50. PubMed ID: 6172866
    [No Abstract]   [Full Text] [Related]  

  • 19. Identification of highly potent N-acylethanolamine acid amidase (NAAA) inhibitors: Optimization of the terminal phenyl moiety of oxazolidone derivatives.
    Li Y; Chen Q; Yang L; Li Y; Zhang Y; Qiu Y; Ren J; Lu C
    Eur J Med Chem; 2017 Oct; 139():214-221. PubMed ID: 28802121
    [TBL] [Abstract][Full Text] [Related]  

  • 20. The physical chemistry of the gelation of sickle hemoglobin.
    Briehl RW
    Tex Rep Biol Med; 1980-1981; 40():207-20. PubMed ID: 6275565
    [No Abstract]   [Full Text] [Related]  

    [Next]    [New Search]
    of 4.